Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Raphael Pharmaceutical Inc. is a biotech company specializing in the discovery and development of cannabinoid-based therapies for autoimmune, inflammatory, and respiratory conditions. Its core focus is on developing CBD-derived drug candidates for rheumatoid arthritis, COVID-19-related hyperinflammation, and asthma. The company collaborates with research institutions, relies on third-party manufacturing, and aims to obtain regulatory approvals for innovative, plant-based medicines targeting unmet medical needs worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.